8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
08
Feb
-
09
Feb
2023
When
San Diego

USA
Where

Leveraging next gen technologies beyond conventional biomarker drug discovery! MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

Similar Events

You May Like

Event

MarketsandMarkets

0/5
(0)

In the decade of the 2020s, the B2B world will see $25 trillion worth of disruptive revenue shifts. Organizations globally are navigating both the opportunities and risks that are consequent.

08 - 09 Feb 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Director, Translational Sciences
Associate Director, Medical & Scientific Affairs
Scientist
CEO and President
Regional Medical Affairs Director
Principal Scientist
Global Director, Biomarkers and CDx
Vice President
Associate Director
Chief Scientific Officer and Company Director
President & Chief Scientific Officer
Executive Director and Distinguished Scientist, Companion Diagnostics

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Owlstone Medical

Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.

Proteome Sciences plc

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids.

Precision Antibody

Celebrating it’s 20 th year in business, Precision Antibody has found itself in the forefront of the Custom Antibody industry.

BD Biosciences

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care.

EpigenDx, Inc.

EpigenDx was incorporated in 2006 as a genomic and epigenomic research company specializing in disease biomarker discovery, validation and molecular diagnosis, with an unmatched expertise in the field of DNA methylation analysis.

Organizer

Get emails from us

Thank you
Oops! Something went wrong